Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.43 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylamine SCHEMBL365405 | 1.00 | — | — | |
| Butylamine SCHEMBL465098 | 1.00 | DNM1 (0.67) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL8966219 | 1.00 | DNM1 (0.67) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL27785480 | 0.96 | DNM1 (0.62) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL8352628 | 0.96 | DNM1 (0.71) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL8559 | 0.96 | — | — | |
| Butylamine SCHEMBL23013365 | 0.92 | — | — | |
| Butylamine SCHEMBL15124637 | 0.92 | DNM1 (0.73) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL3786115 | 0.92 | DNM1 (0.67) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Butylamine SCHEMBL23013363 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1360238-B1 | DATA STORAGE MEDIA CONTAINING TRANSPARENT POLYCARBONATE BLENDS | SABIC INNOVATIVE PLASTICS IP (NL) | 2012-01-11 | — | — | EP | disclosed |
| US-20090233910-A1 | Npy antagonists, preparation and uses | CEREP (FR) | 2009-09-17 | — | — | US | disclosed |
| US-7199239-B2 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2007-04-03 | — | — | US | disclosed |
| US-20060074111-A1 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2006-04-06 | — | — | US | disclosed |
| US-6949279-B2 | Data storage media containing transparent polycarbonate blends | GENERAL ELECTRIC COMPANY (US) | 2005-09-27 | — | — | US | disclosed |
| US-6936324-B2 | Data storage media containing transparent polycarbonate blends | GENERAL ELECTRIC COMPANY (US) | 2005-08-30 | — | — | US | disclosed |
| US-6933034-B2 | Data storage media containing transparent polycarbonate blends | GENERAL ELECTRIC COMPANY (US) | 2005-08-23 | — | — | US | disclosed |
| EP-1274763-B1 | PROCESS FOR REDISTRIBUTION OF POLYCARBONATE | GEN ELECTRIC (US) | 2005-07-20 | — | — | EP | disclosed |
| EP-1513795-A2 | PROPIONIC ACID DERIVATIVES AND THEIR USE AS HPPARS ACTIVATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-03-16 | — | — | EP | disclosed |
| US-20040024125-A1 | Data storage media containing transparent polycarbonate blends | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2004-02-05 | — | — | US | disclosed |
| EP-0946508-A1 | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS | Du Pont Pharmaceuticals Company (US) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998028269-A1 | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| EP-0761714-A2 | Method for improving catalyst efficiency during polycarbonate redistribution | GENERAL ELECTRIC COMPANY (US) | 1997-03-12 | — | — | EP | disclosed |
| EP-0722967-A2 | Redistribution of organic polyestercarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1996-07-24 | — | — | EP | disclosed |
| US-5521275-A | MELT EQUILIBRATING POLYCARBONATE BLEND AND A REDISTRIBUTION CATALYST WITHIN A EXTRUDER THAT PRODUCES A MELT SEAL | GENERAL ELECTRIC COMPANY (US) | 1996-05-28 | — | — | US | disclosed |
| US-5414057-A | Redistribution of organic polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1995-05-09 | — | — | US | disclosed |
| EP-0599540-A1 | Polycarbonate-titanium dioxide compositions | GENERAL ELECTRIC COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
| EP-0595608-A1 | Redistribution of organic polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1994-05-04 | — | — | EP | disclosed |
| US-5256728-A | Blending in presence of catalyst | GENERAL ELECTRIC COMPANY (US) | 1993-10-26 | — | — | US | disclosed |
| US-4631205-A | Process for producing coherent films of polyacetylene | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | NPY1R, NPY5R, NPY2R | DNM1 1364/4885TSHR 187/4885MEN1 2447/4885 |
| US-20060074111-A1 | Chemical compounds | HDAC3, HAT1, H1-3 | DNM1 3691/4885TSHR 849/4885MEN1 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.